Screener
Axsome Therapeutics AXSM Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's gross profit?
- Axsome Therapeutics (AXSM) reported gross profit of $176.48M in Q1 2026.
- How has Axsome Therapeutics's gross profit changed year-over-year?
- Axsome Therapeutics's gross profit increased by 58.0% year-over-year, from $111.67M to $176.48M.
- What is the long-term trend for Axsome Therapeutics's gross profit?
- Over 3 years (2022 to 2025), Axsome Therapeutics's gross profit has grown at a 136.2% compound annual growth rate (CAGR), from $44.84M to $591.02M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Axsome Therapeutics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude